In vitro activity of fosfomycin against extended-spectrum-β-lactamase-producing Escherichia coli and Klebsiella pneumoniae:: Comparison of susceptibility testing procedures

被引：96

作者：

de Cueto, M ^{[1
]}

López, L ^{[1
]}

Hernández, JR ^{[1
]}

Morillo, C ^{[1
]}

Pascual, A ^{[1
]}

机构：

[1] Univ Seville, Hosp Univ Virgen Macarena, Fac Med, Dept Microbiol, Seville 41009, Spain

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2006年 / 50卷 / 01期

关键词：

D O I：

10.1128/AAC.50.1.368-370.2006

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The agar dilution, broth microdilution, and disk diffusion methods were compared to determine the in vitro susceptibility of 428 extended-spectrum-p-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin. Fosfomycin showed very high activity against all ESBL-producing strains. Excellent agreement between the three susceptibility methods was found for E. coli, whereas marked discrepancies were observed for K. pneumoniae.

引用

页码：368 / 370

页数：3

共 14 条

[1] In-vitro activity of fosfomycin against vancomycin-resistant enterococci [J].

Allerberger, F ;

Klare, I .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (02) :211-217

[2]

Andreatta M, 2001, TATRA MT MATH PUBL, V23, P1

[3] INVITRO SUSCEPTIBILITY TESTING PROCEDURES FOR FOSFOMYCIN TROMETHAMINE [J].

BARRY, AL ;

FUCHS, PC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (06) :1235-1238

[4] Identification and broad dissemination of the CTX-M-14 β-lactamase in different Escherichia coli strains in the northwest area of Spain [J].

Bou, G ;

Cartelle, M ;

Tomas, M ;

Canle, D ;

Molina, F ;

Moure, R ;

Eiros, JM ;

Guerrero, A .

JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (11) :4030-4036

[5]

Clinical and Laboratory Standards Institute, 2005, M100S15 CLSI

[6] Fosfomycin tromethamine susceptibility of outpatient urine isolates of Escherichia coli and Enterococcus faecalis from ten North American medical centres by three methods [J].

Fuchs, PC ;

Barry, AL ;

Brown, SD .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (01) :137-140

[7] Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in spanish hospitals (GEIH-BLEE Project 2002) [J].

Hernández, JR ;

Pascual, A ;

Cantón, R ;

Martinez-Martínez, L .

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2003, 21 (02) :77-82

[8] In vitro activity of fosfomycin against Gram-negative urinary pathogens and the biological cost of fosfomycin resistance [J].

Marchese, A ;

Gualco, L ;

Debbia, EA ;

Schito, GC ;

Schito, AM .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2003, 22 :S53-S59

[9]

*NAT COMM CLIN LAB, 2003, M3A8 NAT COMM CLIN L

[10] Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum β-lactamase production in Klebsiella pneumoniae isolates causing bacteremia [J].

Paterson, DL ;

Mulazimoglu, L ;

Casellas, JM ;

Ko, WC ;

Goossens, H ;

Von Gottberg, A ;

Mohapatra, S ;

Trenholme, GM ;

Klugman, KP ;

McCormack, JG ;

Yu, VL .

CLINICAL INFECTIOUS DISEASES, 2000, 30 (03) :473-478

← 1 2 →